STEVEN LUDTKE to Cell Line, Tumor
This is a "connection" page, showing publications STEVEN LUDTKE has written about Cell Line, Tumor.
Connection Strength
0.033
-
Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlates. Nat Commun. 2025 Sep 30; 16(1):8696.
Score: 0.033